spacer
home > epc > spring 2017 > getting interactive
PUBLICATIONS
European Pharmaceutical Contractor

Getting Interactive

The pharmaceutical market is booming, evidenced by revenue numbers which exceeded the $1 trillion milestone in 2015, as noted in the International Trade Commission’s 2016 Top Markets Report on Pharmaceuticals (1). A good portion of that is invested in research, so there are a lot of promising developments happening in the clinical trial space. Despite these advancements, however, many industry investments in research are wasted due to problems with clinical supply management.

To get to the heart of the issue, 200 studies that wrapped up over the past two years have recently been reviewed. Out of them, 62% of the material packaged and released was not even used – two thirds of supplies never actually made it to a patient, meaning there was unnecessary spending.

Assessing the Costs

What makes up the costs associated with clinical supplies? One of the biggest considerations is drug expenses, which includes everything from production to packaging and storage. For these factors, there are fixed and variable costs that must be closely examined – for example, if a trial has 1,000 patients getting three kits each, 3,000 kits must be produced. It is also important to create an overage as it is impossible to know where those patients are going to be at all times. Buffers are also necessary and it is vital to ensure that sites do not run out of drugs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stefan Dürr has been working with interactive response technologies for 12 years and is currently Senior Director of Project Management at Cenduit. He is responsible for global project management and support services groups at the company with teams in India, Japan, Switzerland and the US. Stefan holds a Master’s of Science in Molecular Biology and is passionate about finding innovative solutions for clinical supply challenges.
spacer
Stefan Dürr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kloeckner Pentaplast Announces Plans for New Lamination Facility


More info >>

White Papers

Case Study: Emerade® Auto-Injector

SHL Group

The Emerade® Auto Injector is an intuitive disposable 2-step auto injector designed to deliver adrenaline via intramuscular injection during emergency use. The exterior of the device has a simple and sleek industrial design with the aim to minimize confusion for users. To achieve the penetration force required for an intramuscular injection while still ensuring the dosage is delivered correctly and needle protection mechanisms are in place, the Emerade Auto Injector is equipped with an advanced 3 spring technology. The device is also available in 3 doses (150mcg, 300mcg, 500mcg), with each recommended for patients of different bodyweights to maximize efficacy.
More info >>

 
Industry Events

CPhI Worldwide 2017

24-26 October 2017, Messe Frankfurt, Germany

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. The exhibition covers every sector of the pharmaceutical market under one roof.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement